Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Lactobacillus Rhamnosus GG (ATCC 53103) in the Modulation of the Inflammatory Process in the Mucosa of Ulcerative Colitis (UC) Patients With Mild-moderate Clinical Activity

NCT04102852 is registered in ClinicalTrials.gov with San Giovanni Addolorata Hospital as lead sponsor.

NCT NCT04102852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04102852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Lactobacillus Rhamnosus GG (ATCC 53103) in the Modulation of the Inflammatory Process in the Mucosa of Ulcerative Colitis (UC) Patients With Mild-moderate Clinical Activity
Lead sponsor
San Giovanni Addolorata Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 2019
Completion date
January 31, 2022
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis chronic mild, ulcerative colitis chronic moderate